home All News open_in_new Full Article

«Resultate überzeugen auf der ganzen Linie»: Aktien von Dottikon ES springen nach Jahreszahlen an

Pharma - Dottikon ES ist im Geschäftsjahr 2024/25 markant gewachsen und hat den Gewinn gesteigert. Der ZKB-Analyst äussert sich positiv und der Kurs schnellt hoch.


today 1 week ago attach_file Other

attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Politics
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other


ID: 1961631833
Add Watch Country

arrow_drop_down